• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Innospec Inc.

    5/30/25 6:04:36 AM ET
    $IOSP
    Major Chemicals
    Industrials
    Get the next $IOSP alert in real time by email
    SD 1 d30187dsd.htm SD SD
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM SD

     

     

    SPECIALIZED DISCLOSURE REPORT

     

     

    Innospec Inc.

    (Exact name of the registrant as specified in its charter)

     

     

     

    Delaware    1-13879    98-0181725

    (State or other jurisdiction

    of incorporation)

      

    (Commission

    file number)

      

    IRS Employer

    Identification No.

    8310 South Valley Highway

    Suite 350

    Englewood

    Colorado

          80112
    (Address of principle executive offices)       (Zip code)

    David B. Jones

    Senior Vice President, General Counsel & Chief Compliance Officer

    (303) 792 5554

    (Name and telephone number, including area code, of the person to contact in connection with this report.)

     

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed:

     

    ☒

    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

     

    ☐

    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended      .

     

     
     


    Section 1 - Conflict Minerals Disclosure

    Item 1.01 Conflict Minerals Disclosure and Report

    Conflict Minerals Disclosure

    This Form SD of Innospec Inc. (the “Company” or “Innospec”) for the year ended December 31, 2024 is filed pursuant to Rule 13p-1 (“Rule”) under the Securities Exchange Act of 1934, as amended. The Rule was adopted by the Securities and Exchange Commission (“SEC”) to implement reporting and disclosure requirements related to “conflict minerals” as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (“Dodd-Frank Act”). Conflict minerals are defined by the SEC as gold, columbite-tantalite (coltan), cassiterite, wolframite or their derivatives, which are limited to tantalum, tin, and tungsten. The Rule imposes certain reporting obligations on SEC registrants whose products contain conflict minerals that are necessary to the functionality or production of their products (such necessary minerals are referred to as “necessary conflict minerals”). For products that contain necessary conflict minerals, the registrant must conduct in good faith a reasonable country of origin inquiry (“RCOI”) designed to determine whether any of the conflict minerals originated in the Democratic Republic of the Congo (“DRC”) or adjoining countries, collectively defined as the “Covered Countries”.

    Commencing in January of each year, Innospec’s Legal Compliance department directs and oversees a review of Innospec’s products, with input from other departments, product managers and other relevant employees, to make a determination as to whether conflict minerals were “necessary to the functionality or production” of any of the products that Innospec manufactured or contracted to manufacture during the prior calendar year. If, as a result of the internal review, the Legal Compliance department determines that conflict minerals were necessary to the functionality or production of any Innospec product manufactured or sold during the prior calendar year, it will commence and oversee an RCOI and otherwise ensure compliance with the Rule.

    From its internal review process the Company determined that, during the year ended December 31, 2024, the Company used five catalysts containing tin as a component (the “Catalysts”) in the manufacture of certain products. These Catalysts are filtered but not washed out of the relevant Company products. The Company was supplied with these Catalysts from four different suppliers. Except for its products containing the Catalysts, the Company does not believe that any of its other products manufactured or sold during 2024 contained necessary conflict minerals.

    In accordance with the Rule, Innospec conducted an RCOI by seeking a certification from each supplier as to the source of the tin contained in the Catalysts. The suppliers represented to the Company in writing that “... the tin based products that it manufactures are produced from tin sourced from smelters on the RMI compliant smelter list” and also provided a list containing names of the tin smelters which the supplier used, and the countries where such smelters are located (the “Supplier List”). According to that Supplier List, one of the suppliers advised that the tin may have been sourced from a (RMI compliant) smelter in a Covered Country.

    Based on the results of its RCOI, the Company believes that the tin contained in the Catalysts all originated from smelters which are RMI compliant.

    This conflict minerals disclosure is publicly available on the Company’s website at https://innospec.com/about- us/supplier-relations/

    Item 1.02 Exhibit

    Not Applicable.

    Section 2 – Resource Extraction Issuer Disclosure

    Item 2.01 Resource Extraction Issuer Disclosure and Report

    Not applicable.


    Section 3 – Exhibits

    Item 3.01 Exhibits

    Not applicable.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

     

    INNOSPEC INC.     
    (Registrant)                 
    LOGO     
    David B. Jones      May 30, 2025

    SVP, General Counsel and

    Chief Compliance Officer

        
    Get the next $IOSP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IOSP

    DatePrice TargetRatingAnalyst
    4/21/2025$115.00Neutral → Buy
    Seaport Research Partners
    3/30/2022Neutral
    Seaport Research Partners
    More analyst ratings

    $IOSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrette Leslie J sold $40,421 worth of shares (446 units at $90.63), decreasing direct ownership by 8% to 5,497 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:11:51 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SVP, HUMAN RESOURCES Griffin Hardy Louis Iii covered exercise/tax liability with 600 shares, decreasing direct ownership by 8% to 6,742 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:05:37 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SVP, Corporate Dev and IR Barnes Corbin covered exercise/tax liability with 740 shares, decreasing direct ownership by 8% to 8,998 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:01:11 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Innospec Reports Second Quarter 2025 Financial Results

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses Focus on sequential gross margin and operating income improvement in the second half of the year Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26 ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025. Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million o

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Schedules Second Quarter 2025 Earnings Release and Conference Call

    ENGLEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release second quarter 2025 earnings results on Tuesday, August 5, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 6, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal

    7/2/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Reports First Quarter 2025 Financial Results

    Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

    5/8/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Innospec upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Innospec from Neutral to Buy and set a new price target of $115.00

    4/21/25 8:30:53 AM ET
    $IOSP
    Major Chemicals
    Industrials

    Seaport Research Partners initiated coverage on Innospec

    Seaport Research Partners initiated coverage of Innospec with a rating of Neutral

    3/30/22 7:37:48 AM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrette Leslie J bought $15,135 worth of shares (143 units at $105.84), increasing direct ownership by 3% to 4,734 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    8/14/24 6:31:38 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Parrette Leslie J bought $24,867 worth of shares (189 units at $131.57), increasing direct ownership by 4% to 4,591 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/20/24 6:07:17 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Parrette Leslie J bought $50,824 worth of shares (410 units at $123.96), increasing direct ownership by 13% to 3,620 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    2/23/24 6:19:14 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    SEC Filings

    View All

    SEC Form 10-Q filed by Innospec Inc.

    10-Q - INNOSPEC INC. (0001054905) (Filer)

    8/6/25 10:25:38 AM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form 8-K filed by Innospec Inc.

    8-K - INNOSPEC INC. (0001054905) (Filer)

    8/6/25 6:07:39 AM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SD filed by Innospec Inc.

    SD - INNOSPEC INC. (0001054905) (Filer)

    5/30/25 6:04:36 AM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Financials

    Live finance-specific insights

    View All

    Innospec Reports Second Quarter 2025 Financial Results

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses Focus on sequential gross margin and operating income improvement in the second half of the year Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26 ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025. Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million o

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Schedules Second Quarter 2025 Earnings Release and Conference Call

    ENGLEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release second quarter 2025 earnings results on Tuesday, August 5, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 6, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal

    7/2/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Reports First Quarter 2025 Financial Results

    Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

    5/8/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Leadership Updates

    Live Leadership Updates

    View All

    Innospec Appoints Leslie J. Parrette as Non-Employee Director

    ENGLEWOOD, Colo., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it has appointed Mr. Leslie J. Parrette as a non-employee director, effective January 1, 2022. Mr. Parrette has 14 years experience in private practice as a corporate and transaction lawyer. He subsequently spent 20 years as General Counsel for public companies in domestic and international markets. Most recently, he served as Senior Vice President, General Counsel, Compliance Officer and Corporate Secretary of Novelis Inc., a leading producer of flat-rolled aluminum products and the world's largest recycler of aluminum. He is Founder and President of One Page Thinking, a data visualizatio

    12/6/21 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    2/13/24 5:06:27 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    2/9/24 2:18:58 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    1/12/24 8:24:55 AM ET
    $IOSP
    Major Chemicals
    Industrials